Spectrum of mandibular and maxillary pathologies as assessed with dentascan: A pictorial essay
Gurleen Kaur, Uttam B George, Subhash Singla and 2 more
CHRISMED Journal of Health and Research · 2019
doi:10.4103/cjhr.cjhr_29_18 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Introduction: Dentascan is a CT imaging software that provides three dimensional display and high resolution panoramic views of the jaw. It has become an important aspect of evaluation of mandibular and maxillary pathologies due to its advantages over two dimensional techniques and conventional CT. Materials and Methods: 60 patients presenting with jaw lesions, were studied using Dentascan software. The aim of the study was to explore the spectrum of findings in various mandibular and maxillary pathologies as well as define their extent and involvement using DentaScan. Results: Impacted mandibular molars constituted 45% of cases followed by tumors and inflammatory lesions (36.6 %). Of the 22 tumors and inflammatory lesions, giant cell granulomas and radicular cysts, accounted for 22.7% each while osteomyelitis constituted 18%. Other lesions included osteosarcoma, buccal space infection, ameloblastoma, adenomatoid odontogenic tumor, dentigerous cysts and carcinoma alveolus. Trauma leading to facial fractures and TMJ pathologies constituted 8.3% and 10% of cases respectively. Conclusion: DentaScan is a valuable tool in evaluation of maxillary and mandibular pathologies including tumors/cysts, inflammatory /infectious lesions, TMJ ankylosis and facial fractures. By providing information superior to radiographs and conventional computed tomography, it plays a valuable role in pre-operative assessment of various pathologies.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.